M&T Bank Corp Cuts Stock Position in Mettler-Toledo International, Inc. (NYSE:MTD)

M&T Bank Corp lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 12.4% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 4,003 shares of the medical instruments supplier's stock after selling 568 shares during the period. M&T Bank Corp's holdings in Mettler-Toledo International were worth $4,727,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of MTD. Farther Finance Advisors LLC lifted its stake in shares of Mettler-Toledo International by 14.3% in the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock worth $78,000 after purchasing an additional 8 shares during the period. Steward Partners Investment Advisory LLC lifted its stake in shares of Mettler-Toledo International by 3.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock worth $374,000 after purchasing an additional 9 shares during the period. Albion Financial Group UT lifted its stake in shares of Mettler-Toledo International by 1.5% in the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after purchasing an additional 11 shares during the period. Sequoia Financial Advisors LLC lifted its stake in shares of Mettler-Toledo International by 1.8% in the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares during the period. Finally, TD Private Client Wealth LLC lifted its stake in shares of Mettler-Toledo International by 5.4% in the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after purchasing an additional 11 shares during the period. Institutional investors own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director directly owned 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Trading Down 1.0%

NYSE MTD traded down $12.63 on Friday, reaching $1,223.62. 118,779 shares of the stock were exchanged, compared to its average volume of 150,546. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,546.93. The company's 50-day simple moving average is $1,165.26 and its two-hundred day simple moving average is $1,195.29. The firm has a market capitalization of $25.43 billion, a PE ratio of 30.51, a PEG ratio of 3.76 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The business had revenue of $883.74 million during the quarter, compared to analyst estimates of $876.61 million. During the same period last year, the firm posted $8.89 EPS. The company's revenue was down 4.6% on a year-over-year basis. Sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

MTD has been the topic of several recent research reports. Barclays initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective on the stock. Bank of America increased their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective on the stock in a research note on Monday, April 7th. Robert W. Baird decreased their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Finally, UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $1,280.90.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.